Published in Gene Therapy Weekly, January 23rd, 2003
This discovery resulted in the reclassification of mda-7 as interleukin-24, or IL-24. Interleukins are a class of proteins that regulate the immune system and have been shown to be integral in controlling cancer. These data were described in oral presentations at the 11th International Conference on Gene Therapy of Cancer, recently held in San Diego, California.
One presentation described data that mda-7 is a multifunctional...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.